Lipoprotein(a) and Atherosclerotic Cardiovascular Diseases: Evidence from Chinese Population

Cardiovascular disease (CVD) is the leading cause of mortality worldwide. Multiple factors are involved in CVD, and emerging data indicate that lipoprotein(a) (Lp(a)) may be associated with atherosclerotic cardiovascular disease (ASCVD) independent of other traditional risk factors. Lp(a) has been i...

Full description

Saved in:
Bibliographic Details
Main Author: Jianjun Li
Format: Article
Language:English
Published: Wolters Kluwer Health/LWW 2023-03-01
Series:Cardiology Discovery
Online Access:http://journals.lww.com/10.1097/CD9.0000000000000059
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850151680527564800
author Jianjun Li
author_facet Jianjun Li
author_sort Jianjun Li
collection DOAJ
description Cardiovascular disease (CVD) is the leading cause of mortality worldwide. Multiple factors are involved in CVD, and emerging data indicate that lipoprotein(a) (Lp(a)) may be associated with atherosclerotic cardiovascular disease (ASCVD) independent of other traditional risk factors. Lp(a) has been identified as a novel therapeutic target. Previous studies on the influence of Lp(a) in CVD have mainly used in western populations. In this review, the association of plasma Lp(a) concentration with ASCVD was summarized, with regards to epidemiological, population-based observational, and pathological studies in Chinese populations. Lp(a) mutations and copy number variations in Chinese populations are also explored. Finally, the impact of plasma Lp(a) levels on patients with type 2 diabetes mellitus, cancer, and familial hypercholesterolemia are discussed.
format Article
id doaj-art-0c44d3a271ea4d8aa3baacd8d9ccc81d
institution OA Journals
issn 2096-952X
2693-8499
language English
publishDate 2023-03-01
publisher Wolters Kluwer Health/LWW
record_format Article
series Cardiology Discovery
spelling doaj-art-0c44d3a271ea4d8aa3baacd8d9ccc81d2025-08-20T02:26:09ZengWolters Kluwer Health/LWWCardiology Discovery2096-952X2693-84992023-03-0131404710.1097/CD9.0000000000000059202303000-00006Lipoprotein(a) and Atherosclerotic Cardiovascular Diseases: Evidence from Chinese PopulationJianjun Li0Cardiometabolic Center, Fuwai Hospital, Chinese Academy of Medical Sciences, Beijing 100037, China.Cardiovascular disease (CVD) is the leading cause of mortality worldwide. Multiple factors are involved in CVD, and emerging data indicate that lipoprotein(a) (Lp(a)) may be associated with atherosclerotic cardiovascular disease (ASCVD) independent of other traditional risk factors. Lp(a) has been identified as a novel therapeutic target. Previous studies on the influence of Lp(a) in CVD have mainly used in western populations. In this review, the association of plasma Lp(a) concentration with ASCVD was summarized, with regards to epidemiological, population-based observational, and pathological studies in Chinese populations. Lp(a) mutations and copy number variations in Chinese populations are also explored. Finally, the impact of plasma Lp(a) levels on patients with type 2 diabetes mellitus, cancer, and familial hypercholesterolemia are discussed.http://journals.lww.com/10.1097/CD9.0000000000000059
spellingShingle Jianjun Li
Lipoprotein(a) and Atherosclerotic Cardiovascular Diseases: Evidence from Chinese Population
Cardiology Discovery
title Lipoprotein(a) and Atherosclerotic Cardiovascular Diseases: Evidence from Chinese Population
title_full Lipoprotein(a) and Atherosclerotic Cardiovascular Diseases: Evidence from Chinese Population
title_fullStr Lipoprotein(a) and Atherosclerotic Cardiovascular Diseases: Evidence from Chinese Population
title_full_unstemmed Lipoprotein(a) and Atherosclerotic Cardiovascular Diseases: Evidence from Chinese Population
title_short Lipoprotein(a) and Atherosclerotic Cardiovascular Diseases: Evidence from Chinese Population
title_sort lipoprotein a and atherosclerotic cardiovascular diseases evidence from chinese population
url http://journals.lww.com/10.1097/CD9.0000000000000059
work_keys_str_mv AT jianjunli lipoproteinaandatheroscleroticcardiovasculardiseasesevidencefromchinesepopulation